Opus Genetics, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2022 | — | $17.3M | $19.2M |
| Jun 2022 | — | $14.6M | $17.0M |
| Sep 2022 | — | $11.9M | $13.9M |
| Dec 2022 | — | $46.2M | $42.6M |
| Mar 2023 | — | $41.3M | $39.0M |
| Jun 2023 | — | $37.7M | $40.0M |
| Sep 2023 | — | $50.3M | $42.4M |
| Dec 2023 | — | $49.9M | $50.5M |
| Mar 2024 | — | $46.1M | $47.2M |
| Jun 2024 | — | $40.6M | $41.4M |
| Sep 2024 | — | $34.3M | $36.6M |
| Dec 2024 | $0 | $6.7M | $30.3M |
| Mar 2025 | — | $5.1M | $41.8M |
| Jun 2025 | $1.0M | $17.5M | $32.4M |
| Sep 2025 | $1.1M | $6.0M | $30.8M |
| Dec 2025 | $1.1M | $15.3M | $45.1M |
| Mar 2026 | $1.2M | $-45.8M | $60.0M |
| Apr 2026 | $35.3M | — | — |
| Jun 2026 | $35.3M | $-13.0M | $88.8M |